Chemotherapy News and Research

Latest Chemotherapy News and Research

EpiCept announces opinion by European Regulatory Authority on Ceplene

EpiCept Corporation has announced that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued, as expected following the trend vote announced last month, a negative opinion regarding the marketing authorization application (MAA) for Ceplene (histamine dihydrochloride) for the remission maintenance and prevention of relapse of patients with Acute Myeloid Leukemia (AML) in first remission.

24 Mar 2008

Shorter radiotherapy courses for breast cancer just as safe and effective

British researchers say when it comes to treating breast cancer in women, shorter courses of radiation at a lower overall dose appear to be just as safe and effective as the standard treatment delivered over a longer period of time.

21 Mar 2008

Women's sexual disorders get medical attention in new Stanford program

Medicine is finally opening the bedroom door to women. When the male erectile dysfunction drug Viagra was approved by the U.S. Food and Drug Administration in 1998, many middle-aged men experienced a new lease on life, or at least on life in the bedroom.

19 Mar 2008

What change does prokineticin 2/Bv8 have in human hepatocellular carcinoma?

Liver hepatocarcinoma is a highly vascularized cancer, and more and more research is focused on the molecules controlling angiogenesis.

19 Mar 2008

Live demonstration of robotic radical prostatectomy

One of the nation's top robotic surgeons will remove the cancerous prostate of a Southern Tier man during a live demonstration of robotic surgery on Wednesday, March 19.

19 Mar 2008

Possible cause of chemobrain found

Thanks to early diagnosis and chemotherapy, more women survive breast cancer than ever before.

19 Mar 2008

First 3-D view of anti-cancer agent

Researchers from the Indiana University School of Medicine and the Purdue School of Science at Indiana University-Purdue University Indianapolis have created the first three-dimensional image of how a well-established chemotherapy agent targets and binds to DNA.

19 Mar 2008

Long-term follow-up after percutaneous pulmonary radiofrequency ablation

Radiofrequency ablation (RFA) - an interventional treatment that "cooks" and kills lung cancer tumors with heat - greatly improves survival time from primary or metastatic inoperable lung tumors, according to a study released at the Society of Interventional Radiology's 33rd Annual Scientific Meeting.

18 Mar 2008

Study examines changes in quality of life after head and neck cancer treatment

In the year following their first treatment, patients with head and neck cancer report declines in their physical quality of life but improvements in their mental health quality of life, according to a report in the March issue of Archives of Otolaryngology-Head & Neck Surgery.

18 Mar 2008

New technique detects early stages of colon cancer without a biopsy

Doctors may one day be able to detect early stages of colon cancer without a biopsy, using a new technique developed by researchers at the Stanford University School of Medicine.

18 Mar 2008

New diagnostic test for cancer promises less trauma for patients

A rapid new diagnostic test developed by Sydney researchers will mean fewer tests and less trauma for cancer patients says Richard Christopherson, who has a Personal Chair in the School of Molecular and Microbial Biosciences in the Faculty of Science.

17 Mar 2008

Researchers discover signaling system that halts the growth of a childhood brain cancer

A discovery by St. Jude Children's Research Hospital scientists suggests a safer way to treat medulloblastoma, a rare but often fatal childhood brain tumor.

17 Mar 2008

Researchers study new drug and indications for heated chemotherapy treatment

Studies have shown that surgery combined with Intraperitoneal Hyperthermic Chemotherapy (IPHC) can improve survival rates for select patients with peritoneal carcinoma (cancer of the lining of the abdominal cavity) that has spread from colorectal or appendix cancer.

17 Mar 2008

Modified virus vaccine shows promise in mouse model of breast cancer

Researchers have shown that vaccinating mice with a modified form of a virus containing proteins from breast cancer cells can kill large breast cancer tumors and tumors that have spread to the lungs.

17 Mar 2008

Breast cancer more aggressive among overweight or obese women

Women with breast cancer have more aggressive disease and lower survival rates if they are overweight or obese, according to findings published in the March 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.

17 Mar 2008

BMI may serve as prognostic tool for advanced, aggressive breast cancers

Body Mass Index (BMI), the measure of a person's fat based on their height and weight, may be an effective prognostic tool for specific types of breast cancer, according to research from The University of Texas M. D. Anderson Cancer Center.

17 Mar 2008

A long-term survival offered by resection of solid-pseudopapillary tumor of the pancreas?

The article published in volume 14 issue 6 of World Journal of Gastroenterology reports on one patient who presented to Dr Cosimo Sperti of University of Padua, Padova, Italy, in 2001 after an exploratory laparotomy performed in another hospital for an unresectable pancreatic cystic mass that had infiltrated the portal vein.

14 Mar 2008

Researchers find benefit for lymphoma patients in combined PET-CT scanning

Combined positron emission tomography (PET) and computed tomography (CT) imaging of lymphoma patients is a more effective method to evaluate response to radiation therapy, and may help patients avoid unnecessary follow-up treatments, a study by researchers at the University of Southern California (USC) suggests.

13 Mar 2008

AstraZeneca completes enrollment in phase III studies of cancer drug vandetanib

AstraZeneca has announced that it has completed patient enrollment in two pivotal Phase III studies for vandetanib, the company's investigational, once-daily oral anti-cancer drug, for the second-line treatment of non-small cell lung cancer (NSCLC).

13 Mar 2008

DNA detectives find genetic markers for lung cancers most likely to recur

Researchers at the Johns Hopkins Kimmel Cancer Center have uncovered clearly recognizable genetic alterations in tumors and tissue removed from patients with early-stage lung cancers that look like good predictors of which of these cancers are more likely to recur.

13 Mar 2008